4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.
Carella AM, Santini G, Martinengo M, Giordano D, Nati S, Congiu A, Cerri R, Risso M, Damasio E, Rossi E, et al.
Carella AM, et al. Among authors: martinengo m.
Cancer. 1985 Apr 1;55(7):1452-4. doi: 10.1002/1097-0142(19850401)55:7<1452::aid-cncr2820550705>3.0.co;2-d.
Cancer. 1985.
PMID: 3856461